Supplementary Table S5 from Discovery and Characterization of VPRBP/DCAF1 Kinase Inhibitor Analogs as Microtubular Destabilizing Agents with Potent Antimyeloma Activity

抗骨髓瘤药物

BioPrint VPR8

Figshare2026-03-02 更新80

Mithramycin Exerts an Anti-Myeloma Effect and Displays Anti-Angiogenic Effects through Up-Regulation of Anti-Angiogenic Factors

抗骨髓瘤药物

抗血管生成治疗

Mithramycin (MTM), a cytotoxic compound, is currently being investigated for its anti-angiogenic activity that seems to be mediated through an inhibition of the transcription factor SP1. In this study

Figshare2016-01-18 更新40

B Cell Maturation Antigen Targeted Therapy Market

肿瘤免疫治疗

抗骨髓瘤药物

Report of B Cell Maturation Antigen Targeted Therapy Market is currently supplying a comprehensive analysis of many things which are liable for economy growth and factors which could play an important

IMR REPORTS40

Supplementary Table S6 from Discovery and Characterization of VPRBP/DCAF1 Kinase Inhibitor Analogs as Microtubular Destabilizing Agents with Potent Antimyeloma Activity

资源简介：

Supplementary Table S6 from Discovery and Characterization of VPRBP/DCAF1 Kinase Inhibitor Analogs as Microtubular Destabilizing Agents with Potent Antimyeloma Activity

资源简介：

相关数据集